Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sheila M Crean"'
Autor:
Nandini Hadker, Suchita Garg, Arthi B Chandran, Sheila M Crean, Michael McNett, Stuart L Silverman
Publikováno v:
Pain Research and Management, Vol 16, Iss 6, Pp 440-444 (2011)
OBJECTIVES: To describe beliefs and practice patterns of primary care physicians (PCPs) providing fibromyalgia (FM) care, and to characterize differences between PCPs who report being able to provide timely and beneficial care versus the remaining PC
Externí odkaz:
https://doaj.org/article/324257ba792f4c5baf03ec07963cd25e
Autor:
Juliane Gartemann, Elizabeth Caffrey, Carsten Rausch, Sheila M Crean, Gary M. Creed, Nandini Hadker
Publikováno v:
Nursing in Critical Care. 17:279-284
Aims and objectives: The cumulative time that critical care nurses spend implementing a tight glycaemic control (TGC) protocol was estimated in a time-in-motion (TiM) study conducted in a hospital in the UK. Background: TGC protocols were introduced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea9289f04a683f32f2e4d4f2972f0c6
https://doi.org/10.1111/j.1478-5153.2012.00506.x
https://doi.org/10.1111/j.1478-5153.2012.00506.x
Autor:
Stuart L. Silverman, Arthi Chandran, Michael McNett, Suchita Garg, Sheila M Crean, Nandini Hadker
Publikováno v:
Pain Research and Management, Vol 16, Iss 6, Pp 440-444 (2011)
OBJECTIVES: To describe beliefs and practice patterns of primary care physicians (PCPs) providing fibromyalgia (FM) care, and to characterize differences between PCPs who report being able to provide timely and beneficial care versus the remaining PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c9acc9b91712ef109cecceb6491551
https://doi.org/10.1155/2011/367059
https://doi.org/10.1155/2011/367059
Autor:
Sheila M. Crean, H. Michael Arrighi, Nicole L. Baker, Jenna Collins, Michael N. Cook, Catherine J. Mercaldi, Alex Ward
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 31:20-30
Background: The Ε4 allele of apolipoprotein E (APOE) is associated with Alzheimer’s disease (AD). However, attributable risk due to APOE4 varies by region and by race/ethnicity. Methods: A literature review and meta-analysis were conducted to esti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78f87680ff8b8cd6195212e56b2ec7d9
https://doi.org/10.1159/000321984
https://doi.org/10.1159/000321984
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 17:164-170
Antibodies to bovine and human coagulation proteins have been reported to develop in some patients receiving perioperative exposure to topical bovine thrombin. To estimate the prevalence of antihuman and antibovine thrombin and factor V antibodies in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bca76f72dcc7e56ede5fe0c5f2ad65d
https://doi.org/10.1177/1076029610384109
https://doi.org/10.1177/1076029610384109
Autor:
Teresa A. Spoon, Sheila M. Crean, Mel C. Schroeder, Amy M. Delaney, William A. Denny, James M. Hamby, Andrew M. Thompson, H. D. Hollis Showalter
Publikováno v:
Journal of Medicinal Chemistry. 48:4628-4653
7-Substituted 3-aryl-1,6-naphthyridine-2,7-diamines and related 2-ureas are inhibitors of fibroblast growth factor receptor-1 (FGFR-1) and vascular endothelial growth factor receptor-2 (VEGFR-2). 3-(3,5-Dimethoxyphenyl) and 3-phenyl analogues were pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b7b8e574b8db358b15d62c303681173
https://doi.org/10.1021/jm0500931
https://doi.org/10.1021/jm0500931
Autor:
Catherine J. Mercaldi, Alex Ward, H. Michael Arrighi, Michael N. Cook, Sheila M. Crean, Nicole L. Baker, Jenna Collins
Publikováno v:
Alzheimer's & Dementia. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::514d9308e4ffc12e712e3978e528b3ec
https://doi.org/10.1016/j.jalz.2010.05.1561
https://doi.org/10.1016/j.jalz.2010.05.1561
Autor:
Alan J. Kraker, William L. Elliott, Sheila M. Crean, Tawny K. Dahring, Charles W. Moore, Patrick J. Grohar, Cleo J. C. Connolly, Mark R. Barvian, Gina Lu, H. D. Hollis Showalter, Patrick Vincent, Terry C. Major, and Annette M. Doherty, Robert L. Panek, Denise L. Driscoll, James M. Hamby, Mel C. Schroeder, Stacey L. Boushelle, Brian L. Batley, R. Thomas Winters
Publikováno v:
Journal of medicinal chemistry. 44(12)
In continuing our search for medicinal agents to treat proliferative diseases, we have discovered 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas as a novel class of soluble, potent, broadly active tyrosine kinase (TK) inhibitors. An efficient r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::404cfa4f92f436aa35b392e52070e9a2
https://pubmed.ncbi.nlm.nih.gov/11384237
https://pubmed.ncbi.nlm.nih.gov/11384237
Autor:
Gregory J. LaRosa, Sheila M. Crean, Debra Kellner, Sheila K. Sanders, Peter A. Boxer, Stephen W. Hunt
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 165(9)
The monocyte chemotactic protein-1 (MCP-1) receptor (MCP-1R) is expressed on monocytes, a subpopulation of memory T lymphocytes, and basophils. Two alternatively spliced forms of MCP-1R, CCR2A and CCR2B, exist and differ only in their carboxyl-termin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b8876445b5a85705f11df60f8c05e2
https://pubmed.ncbi.nlm.nih.gov/11046012
https://pubmed.ncbi.nlm.nih.gov/11046012